Biopsy involves removal of cells or tissues from tumors located in various parts of the body and the devices used for this process are called biopsy devices. Biopsies are usually performed to identify and diagnose if the tumor is cancerous before designing a suitable treatment plan for the patient. These procedures are performed in two ways: needle-based minimally invasive procedures and open surgical procedures. Needle-based biopsy guns are handheld devices, which include a motor assembly attached to a biopsy needle, used to collect tissue samples from a patient’s body to detect malignancies.
These devices may be automatic, semiautomatic, or manual, with a spring-loaded mechanism for a minimally invasive insertion through the skin to obtain samples for further laboratory testing. Physicians prefer conducting a minimally invasive needle-based procedure first, to obtain a sample of the timer to determine if it is malignant and needs to be surgically removed. The procedure is performed using image-guidance modalities such as X-ray imaging, magnetic resonance imaging (MRI), computed tomography (CT), and ultrasound imaging. Biopsy devices use of three main types of needle-based technologies such as vacuum-assisted, core needle, and fine needle aspiration to draw samples.
The global Needle Based Biopsy Guns Market is subject to rapid innovation and technological advancements, leading to constant product development ensuring better patient comfort and lesser trauma during and after surgery. Competitive pricing of products and reimbursement for biopsy procedures lead to higher adoption of biopsy devices, thereby driving the market. Expansion of the global needle based biopsy guns market is directly proportional to the incidence of cancer cases globally.
According to the World Health Organization, in 2030, deaths caused due to cancer are expected to reach 13 billion worldwide. A rapid growth in incidence of cancer across the globe are anticipated to increase the number of patients undergoing biopsies. This, in turn, increases the adoption of needle based biopsy guns thereby, driving the market. Moreover, rapidly aging population are expected to further propel the global needle based biopsy guns market. Researchers consider cancer to be an age-related disease. Research reports suggest that patients over the age of 50 are more susceptible to cancer of the cervical, breast, and prostate. This is anticipated to propel the market during the forecast period.
Request to View Brochure of Report -
The global needle based biopsy guns market can be segmented based on application, product type, and geography. In terms of application, the global needle based biopsy guns market is divided into vacuum-assisted biopsy devices (VAB), core needle biopsy devices (CNB), and fine needle aspiration biopsy devices (FNAB). Vacuum-assisted biopsy devices allows removal of larger tissue samples from the skin or breast without the need of an open surgical procedure. Based on product type, the needle based biopsy guns can be classified into disposable and reusable guns.
The global needle based biopsy guns market can been categorized into five regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominates the global needle based biopsy guns market, followed by Europe. Expansion of the market in these region can be attributed to growing incidence of cancer, particularly in developed nations. The U.S. has a large number of cancer patients globally. Asia Pacific market constitutes Japan, China, India, Singapore, Malaysia, Thailand, and other Asian countries The global needle based biopsy guns market in Asia Pacific is projected to expand at a considerable pace due to rise in awareness about biopsy procedures and increase in ageing population.
Comments
Post a Comment